Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc > O.035 - 2mill volume
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(203)
•••
Comment by NotBornLastNiteon Dec 08, 2020 2:58pm
54 Views
Post# 32059792

RE:RE:RE:RE:RE:RE:RE:RE:O.035 - 2mill volume

RE:RE:RE:RE:RE:RE:RE:RE:O.035 - 2mill volumeWe all know ISOL is NOT cash fow positive.  The report in itself simply suggests they have acceptable accounting practices in place.  They have  (finally) a true balance sheet.  No BS, NO crazy outsourse fees. all this mismanagement C$rap..
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities